0026 002675 1 month ago | Other | ¥0.03 Per Share |
0026 002675 6 months ago | Other | ¥0.05 Per Share |
0026 002675 24 Jun 2024 | Other | ¥0.13 Per Share |
0026 002675 10 Jul 2023 | Other | ¥0.15 Per Share |
0026 002675 9 Jun 2022 | Other | ¥0.15 Per Share |
16 May 2025 Date | | 0.16 Cons. EPS | 0.02 EPS |
29 Oct 2024 Date | | - Cons. EPS | 0.07 EPS |
31 Aug 2024 Date | | - Cons. EPS | 0.06 EPS |
17 May 2024 Date | | - Cons. EPS | - EPS |
26 Oct 2023 Date | | - Cons. EPS | 0.12 EPS |
0026 002675 1 month ago | Other | ¥0.03 Per Share |
0026 002675 6 months ago | Other | ¥0.05 Per Share |
0026 002675 24 Jun 2024 | Other | ¥0.13 Per Share |
0026 002675 10 Jul 2023 | Other | ¥0.15 Per Share |
0026 002675 9 Jun 2022 | Other | ¥0.15 Per Share |
16 May 2025 Date | | 0.16 Cons. EPS | 0.02 EPS |
29 Oct 2024 Date | | - Cons. EPS | 0.07 EPS |
31 Aug 2024 Date | | - Cons. EPS | 0.06 EPS |
17 May 2024 Date | | - Cons. EPS | - EPS |
26 Oct 2023 Date | | - Cons. EPS | 0.12 EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Zhi Gang Luo CEO | XSHE Exchange | CNE100001DP5 ISIN |
CN Country | 2,469 Employees | - Last Dividend | 30 Aug 2016 Last Split | 25 May 2012 IPO Date |
Yantai Dongcheng Pharmaceutical Group Co., Ltd., a conglomerate in the pharmaceutical industry, with its subsidiaries, delves into the production and distribution of biochemical Active Pharmaceutical Ingredients (APIs), finished dosage forms, nuclide drugs, and health-related products. These offerings cater to several therapeutic domains, including cardiovascular diseases, antitumor, urology, orthopedics, among others. Established in 1998, this enterprise has its roots and headquarters in Yantai, China, and has expanded its market footprint across approximately 40 countries and regions worldwide, covering Europe, the Americas, Asia Pacific, and other international territories.